1. Home
  2. CABA vs EDHL Comparison

CABA vs EDHL Comparison

Compare CABA & EDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • EDHL
  • Stock Information
  • Founded
  • CABA 2017
  • EDHL 2021
  • Country
  • CABA United States
  • EDHL Hong Kong
  • Employees
  • CABA N/A
  • EDHL N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • EDHL
  • Sector
  • CABA Health Care
  • EDHL
  • Exchange
  • CABA Nasdaq
  • EDHL NYSE
  • Market Cap
  • CABA 157.4M
  • EDHL 137.6M
  • IPO Year
  • CABA 2019
  • EDHL 2025
  • Fundamental
  • Price
  • CABA $1.63
  • EDHL $6.00
  • Analyst Decision
  • CABA Strong Buy
  • EDHL
  • Analyst Count
  • CABA 7
  • EDHL 0
  • Target Price
  • CABA $14.43
  • EDHL N/A
  • AVG Volume (30 Days)
  • CABA 3.0M
  • EDHL 1.1M
  • Earning Date
  • CABA 08-07-2025
  • EDHL 01-01-0001
  • Dividend Yield
  • CABA N/A
  • EDHL N/A
  • EPS Growth
  • CABA N/A
  • EDHL N/A
  • EPS
  • CABA N/A
  • EDHL 0.14
  • Revenue
  • CABA N/A
  • EDHL $2,761,798.00
  • Revenue This Year
  • CABA N/A
  • EDHL N/A
  • Revenue Next Year
  • CABA N/A
  • EDHL N/A
  • P/E Ratio
  • CABA N/A
  • EDHL $42.85
  • Revenue Growth
  • CABA N/A
  • EDHL N/A
  • 52 Week Low
  • CABA $0.99
  • EDHL $3.51
  • 52 Week High
  • CABA $8.77
  • EDHL $6.66
  • Technical
  • Relative Strength Index (RSI)
  • CABA 44.25
  • EDHL N/A
  • Support Level
  • CABA $1.65
  • EDHL N/A
  • Resistance Level
  • CABA $1.68
  • EDHL N/A
  • Average True Range (ATR)
  • CABA 0.14
  • EDHL 0.00
  • MACD
  • CABA -0.05
  • EDHL 0.00
  • Stochastic Oscillator
  • CABA 23.53
  • EDHL 0.00

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About EDHL EVERBRIGHT DIGITAL HOLDING

Everbright Digital Holding Ltd is an integrated marketing solutions provider in Hong Kong that is involved in the metaverse and related technologies, and is providing one-stop digital marketing services for the process of enterprise development. Its digital marketing solutions include metaverse stimulation, virtual reality (VR) and augmented reality (AR) design and creation, creative event planning and management, IP character creation and social media marketing.

Share on Social Networks: